PEOPLE - Molecular Biosystems makes appointment:
This article was originally published in Clinica
Molecular Biosystems, a US developer of ultrasound imaging agents, has appointed Thomas Jurgensen vice-president of legal affairs and general counsel, and Robert Giargiari director of investor relations. In addition, Stephen Keane will take the role of director of business development. Mr Jurgensen was most recently with Ligand Pharmaceuticals and Mr Giargiari with Sequana Therapeutics.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.